D.E. Shaw & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

D.E. Shaw & Co’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,693	Closed	-$452K	–	3538
2023 Q4	$452K	Sell	7,693 -131,920	-94%	-$7.75M	﹤0.01%	2402
2023 Q3	$6.08M	Sell	139,613 -123,325	-47%	-$5.37M	0.01%	1079
2023 Q2	$9.5M	Buy	262,938 +17,352	+7%	+$627K	0.01%	911
2023 Q1	$9.13M	Buy	245,586 +32,285	+15%	+$1.2M	0.01%	1000
2022 Q4	$9.66M	Sell	213,301 -353,129	-62%	-$16M	0.01%	992
2022 Q3	$39.6M	Buy	566,430 +249,522	+79%	+$17.4M	0.05%	314
2022 Q2	$21.3M	Buy	+316,908	New	+$21.3M	0.02%	578
2022 Q1	–	Sell	-2,716	Closed	-$398K	–	4592
2021 Q4	$398K	Sell	2,716 -9,592	-78%	-$1.41M	﹤0.01%	3192
2021 Q3	$2.18M	Sell	12,308 -105,339	-90%	-$18.6M	﹤0.01%	2048
2021 Q2	$19M	Buy	117,647 +35,725	+44%	+$5.77M	0.02%	740
2021 Q1	$14M	Buy	81,922 +18,660	+29%	+$3.2M	0.01%	860
2020 Q4	$13.9M	Buy	63,262 +27,897	+79%	+$6.13M	0.01%	842
2020 Q3	$5.87M	Buy	+35,365	New	+$5.87M	0.01%	1117
2020 Q2	–	Hold	0	–	–	–	2878
2020 Q1	–	Hold	0	–	–	–	2919
2019 Q4	–	Hold	0	–	–	–	2851
2019 Q3	–	Hold	0	–	–	–	2812
2019 Q2	–	Sell	-3,763	Closed	-$276K	–	2785
2019 Q1	$276K	Sell	3,763 -12,462	-77%	-$914K	﹤0.01%	2292
2018 Q4	$688K	Sell	16,225 -43,520	-73%	-$1.85M	﹤0.01%	1989
2018 Q3	$2.81M	Sell	59,745 -145,601	-71%	-$6.86M	﹤0.01%	1384
2018 Q2	$10.1M	Sell	205,346 -78,745	-28%	-$3.88M	0.01%	807
2018 Q1	$8.72M	Sell	284,091 -194,392	-41%	-$5.97M	0.01%	825
2017 Q4	$8.73M	Sell	478,483 -98,599	-17%	-$1.8M	0.01%	828
2017 Q3	$6.75M	Buy	577,082 +495,915	+611%	+$5.8M	0.01%	877
2017 Q2	$296K	Buy	81,167 +33,653	+71%	+$123K	﹤0.01%	2145
2017 Q1	$247K	Sell	47,514 -2,601	-5%	-$13.5K	﹤0.01%	2226
2016 Q4	$238K	Buy	50,115 +39,138	+357%	+$186K	﹤0.01%	2299
2016 Q3	$73K	Buy	+10,977	New	+$73K	﹤0.01%	2433
2015 Q4	–	Sell	-10,650	Closed	-$367K	–	2803
2015 Q3	$367K	Buy	+10,650	New	+$367K	﹤0.01%	2167